Back
Capricor Therapeutics Vs. Protalix BioTherapeutics Industry Stock Comparison
Buy
72
CAPR
Capricor Therapeutics
Last Price:
21.53
Seasonality Move:
-24.28%
Buy
54
PLX
Protalix BioTherapeutics
Last Price:
1.06
Seasonality Move:
42.47%
Buy
72
Capricor Therapeutics (CAPR)
is a Buy
Is Capricor Therapeutics a Buy, Sell or Hold?
- The current Capricor Therapeutics [CAPR] share price is $21.65. The Score for CAPR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- CAPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.08. The Score for PLX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CAPR Stock Price Chart
What is Capricor Therapeutics's stock price today?
-
The Capricor Therapeutics share price today is $21.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CAPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CAPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.52 | Buy |
| Relative Strength Index (14 RSI): | 94.61 | Buy |
| Chaikin Money Flow: | 8515375 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.86 - 13.02) | Buy |
| Bollinger Bands (100): | (2.66 - 8.54) | Buy |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 54.18 | Buy |
| Chaikin Money Flow: | 116384 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.01 - 1.09) | Buy |
| Bollinger Bands (100): | (1 - 1.18) | Sell |
CAPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.47 | Buy |
| 20-day SMA: | 8.85 | Buy |
| 50-day SMA: | 6.05 | Buy |
| 200-day SMA: | 5.35 | Buy |
| 8-day EMA: | 15.11 | Buy |
| 20-day EMA: | 10.74 | Buy |
| 50-day EMA: | 7.52 | Buy |
| 200-day EMA: | 5.55 | Buy |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.05 | Buy |
| 20-day SMA: | 1.07 | Buy |
| 50-day SMA: | 1.03 | Buy |
| 200-day SMA: | 1.26 | Sell |
| 8-day EMA: | 1.05 | Buy |
| 20-day EMA: | 1.05 | Buy |
| 50-day EMA: | 1.05 | Buy |
| 200-day EMA: | 1.23 | Sell |
Capricor Therapeutics Earnings Growth & CAPR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.69 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Capricor Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||